Earnings Scheduled For March 9, 2022
Companies Reporting Before The Bell
• REV Group (NYSE:REVG) is expected to report quarterly earnings at $0.11 per share on revenue of $529.44 million.
Preview: Yield10 Bioscience’s Earnings
Yield10 Bioscience (NASDAQ:YTEN) is set to give its latest quarterly earnings report on Wednesday, 2022-03-09. Here's what investors need to know before the announcement.
Analysts estimate that Yield10 Bioscience will report an earnings per share (EPS) of $-0.63.
46 Stocks Moving In Monday’s Mid-Day Session
Gainers
Houston American Energy Corp. (NYSE: HUSA) jumped 137.4% to $4.5150 amid continued momentum and an increase in the price of oil.
Yield10 Bioscience Announces Update On Camelina Line E3902 Development Program For Producing Low-Carbon Feedstock Oil For Renewable Diesel
Yield10 Bioscience, Inc. (NASDAQ:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced an update on its Camelina line E3902 development program for the purpose of
Yield10 Bioscience Reports Field Test Results Show Seed Oil Content Increase In Camelina, Canola
Yield10 Bioscience, Inc. (NASDAQ:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that 2021 field test results show that the trait C3020 tested in Camelina
Yield10 Bio Shares Quiet Following Circulation Of World Intellectual Property Organization PatentScope Listing For Co.’s ‘GENETICALLY MODIFIED PLANTS THAT EXHIBIT AN INCREASE IN SEED YIELD COMPRISING A FIRST BIOTIN ATTACHMENT…’
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2022036078
From Benzinga’s Global Small Cap Conference: Yield10 Biosciences President & CEO, Oliver Peoples Says Co’s Cash Reserves Will Take The Company Through Until 2023
https://www.youtube.com/watch?v=XkOilNZqoEIhttps://www.youtube.com/watch?v=XkOilNZqoEI